Assignee
LORUS THERAPEUTICS INC
CA·6 granted patents·5 pending applications·61 citations·filing 1994–2010
Top patents by PatentIndex Score
11 records- 0181US7884120B22,4,5-trisubstituted imidazoles and their use as anti-microbial agentsLORUS THERAPEUTICS INC·Filed 2003·Granted Feb 8, 2011·11 cites·20 claims
- 0278US7405205B2Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductaseLORUS THERAPEUTICS INC·Filed 2003·Granted Jul 29, 2008·4 cites·73 claims
- 0372US6551623B1Immunomodulating compositions from bileLORUS THERAPEUTICS INC·Filed 2000·Granted Apr 22, 2003·8 cites·20 claims
- 0468US7968526B2Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancerLORUS THERAPEUTICS INC·Filed 2010·Granted Jun 28, 2011·1 cites·19 claims
- 0568US6596319B2Immunomodulating compositions for treatment of immune system disordersLORUS THERAPEUTICS INC·Filed 2001·Granted Jul 22, 2003·11 cites·8 claims
- 0666US6280774B1Immunomodulating compositions from bileLORUS THERAPEUTICS INC·Filed 1994·Granted Aug 28, 2001·26 cites·7 claims
- 0758US2008279957A1Immunomodulating compositions from bileLORUS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0854US2005192443A1Biological response modifier for the treatment of cancerLORUS THERAPEUTICS INC·Filed 2004·Application pending·0 cites
- 0950US2009118205A2Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of CancerLORUS THERAPEUTICS INC·Filed 2005·Application pending·0 cites
- 1050US2004101569A1Immunomodulating compositions from bileLORUS THERAPEUTICS INC·Filed 2002·Application pending·0 cites
- 1142US2010204305A1Small interfering rna molecules against ribonucleotide reductase and uses thereofLORUS THERAPEUTICS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LORUS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →